Evolution of the Average Target: Sanofi

Data source: Sanofi(SAN)
Evolution of the Average Target - Sanofi

Evolution of the Target Price: Sanofi

Data source: Sanofi(SAN)
Evolution of the Target Price - Sanofi

Changes in Analyst Recommendations: Sanofi

Data source: Sanofi(SAN)
263471470.qMsoTwh-XGQ7lrUwNtlP4Y-Xg2IdChMD57Yaesmpfsw._55EJVs5NBJ84fxDUr0gjLnhzRZKUGRbn99pH_-dGLnGvG13ZUhuLVnvjQ~29f47acb0cd99c7352cc2eeb534791f1
10-26 A Week of Reckoning for Wall Street Zonebourse
10-21 Sanofi : JP Morgan gives a Neutral rating ZD
10-16 RBC Cuts Price Target on Sanofi to EUR75 From EUR80, Keeps Sector Perform Rating MT
10-16 Sanofi : Gets a Neutral rating from RBC ZD
10-15 Sanofi : UBS sticks Neutral ZD
10-14 Nurix Therapeutics' Enterprise Value Remains Underappreciated, RBC Capital Markets Says MT
10-07 Sanofi : Jefferies keeps its Buy rating ZD
10-07 Sanofi : JP Morgan sticks Neutral ZD
10-07 Berenberg Says Sanofi, Regeneron's Expanded Immunology Collaboration Extends 'Dominance' in Atopic Diseases MT
10-06 Sanofi : Berenberg remains its Buy rating ZD
10-01 Sanofi : RBC sticks Neutral ZD
10-01 Sanofi : JP Morgan reiterates its Neutral rating ZD
10-01 Sanofi to invest up to $8bn to expand alliance with Regeneron Zonebourse
10-01 Sanofi : Buy rating from Jefferies ZD
09-30 Regeneron Needs 'Better' Terms in Sanofi Renegotiation, RBC Says MT
09-29 Sanofi : Buy rating from Deutsche Bank ZD
09-17 Sanofi : UBS reiterates its Neutral rating ZD
09-15 Sanofi : Deutsche Bank reiterates its Buy rating ZD
09-14 Sanofi : Deutsche Bank reiterates its Buy rating ZD
09-09 RBC Capital Markets Begins Sanofi's Coverage at Sector Perform MT
09-09 RBC Initiates Sanofi at Sector Perform With EUR80 Price Target MT
09-09 RBC Launches Sanofi Coverage at Sector Perform Amid Management Turnaround, 'Light' Near-term Catalysts MT
09-09 Sanofi : From a Buy to Neutral rating by RBC ZD
09-08 Sanofi : Barclays is Neutral ZD
09-02 Sanofi : Gets a Buy rating from Deutsche Bank ZD

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+4.27%
+4.92%
-0.68%
-2.56%
+13.62%
-2.85%
+22.47%
-10.64%
+0.95%
Average +3.28%
Weighted average by Cap. +3.54%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
74.58EUR
Average target price
93.35EUR
Spread / Average Target
+25.17%
High Price Target
107.20EUR
Spread / Highest target
+43.74%
Low Price Target
75.00EUR
Spread / Lowest Target
+0.56%

Analyst Consensus Detail

Analyst consensus - Sanofi

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Sanofi
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Sanofi